Form 4 for MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Accepted 2022-07-19 00:00:00 ET · period of report 2022-07-15 · accession 0001823239-22-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-19 | 2022-07-15 | MRVI | Leddy Peter Michael | See Remarks | A - Grant | — | +63.5K | 63.5K | New | — |
| D | 2022-07-19 | 2022-07-15 | MRVI | Leddy Peter Michael | See Remarks | A - Grant | $0.00 | +122.9K | 122.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-07-15 | A | A | 63,498 | — | 63,498 | D | — | — | (F1) Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting, subject to the Reporting Person's continued employment with the Issuer. The RSUs will vest in 1/3rd increments on each of July 15, 2023, July 15, 2024, and July 15, 2025, subject to the Reporting Person's continued employment with the Issuer. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2022-07-15 | A | A | 122,893 | $0.00 | 122,893 | D | $24.94 · — to 2032-07-15 | 122,893 Class A Common Stock | (F2) Represents options awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. These options will vest 25% on July 15, 2023 and in equal 1/48th installments each month thereafter, subject to the Reporting Person's continued employment with the Issuer. |